To evaluate the predictive value and mechanism of inflammatory factors in peripheral blood on the prognosis of patients, and to explore the influencing factors of inflammation and tumor microenvironment on the efficacy of neoadjuvant chemotherapy combined with immunotherapy for esophageal cancer. To explore the predictors of neoadjuvant therapy in patients with esophageal squamous cell carcinoma.
None
None
Patients with esophageal cancer
Cohort
Prospective
Not listed
Tumor diameter
The tumor diameter will be measured to evaluate the therapeutic effect
Overall survival
The survival time of patients is calculated from first treatment
Click on the lead sponsor to view all of their trials.
